Abbott Laboratories

Abbott Laboratories Book Value per Share

The Book Value per Share of Abbott Laboratories (ABT) as of Nov 13, 2026 is 29.82 USD. In the previous year, Book Value per Share was 27.27 USD — a change of 9.37% (higher).

Book Value per Share

29.82USD

YoY

9.37%

Last updated:

Book Value per Share of Abbott Laboratories is 2025 29.82 USD. Book Value per Share of Abbott Laboratories was 2024 27.27 USD. It decreases by 9.37% higher compared to the previous year.

The Abbott Laboratories Book Value per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Book Value per Share
Date
Book Value per Share
Jan 1, 2018
17.46 USD
Jan 1, 2019
17.78 USD
Jan 1, 2020
18.76 USD
Jan 1, 2021
20.48 USD
Jan 1, 2022
20.99 USD
Jan 1, 2023
22.08 USD
Jan 1, 2024
27.27 USD
Jan 1, 2025
29.82 USD
The Abbott Laboratories Book Value per Share history
YEARBook Value per ShareYoY
29.82USD+9.37%
27.27USD+23.47%
22.08USD+5.23%
20.99USD+2.47%
20.48USD+9.21%
18.76USD+5.46%
17.78USD+1.85%
17.46USD-1.21%
17.68USD+50.44%
11.75USD-3.17%
12.13USD-1.46%
12.31USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Abbott Laboratories Stock analysis

What does Abbott Laboratories do? Abbott Laboratories is one of the largest companies in the healthcare industry worldwide. The company was founded in 1888 by Dr. Wallace C. Abbott, who aimed to develop innovative and high-quality medical products that would improve people's lives and treat illnesses. Abbott Laboratories' business model is based on the discovery, development, manufacturing, and marketing of healthcare products. These range from pharmaceuticals to diagnostic devices. The company operates in various areas, including pharmaceuticals, nutrition, diagnostics, medical technology, and animal health. In the pharmaceutical field, Abbott Laboratories is a leading provider of generic drugs as well as innovative medications specialized in treating conditions such as Parkinson's disease, cancer, or hypertension. The company is particularly known for developing medications focused on the medical needs of women, such as hormone replacement therapy or birth control pills. In the nutrition field, Abbott Laboratories leads in the development of food and supplements for specific target groups, such as premature infants, cancer patients, or those with digestive problems. Best-selling products include Similac baby formula and Ensure, a nutritional supplement for older adults. In the diagnostics field, Abbott Laboratories develops and manufactures medical diagnostic devices and systems for patient monitoring. This includes blood glucose meters, blood pressure monitors, test strips, and laboratory systems for diagnosing diseases such as diabetes, HIV, or hepatitis. Abbott Laboratories is also a significant player in the medical technology field. The company produces and distributes medical devices such as pacemakers, stents, or artificial joints. These are typically used by doctors and hospitals to optimize patient treatment. In the animal health field, Abbott Laboratories offers a wide range of products and services for agricultural farms and veterinarians. This includes animal medications, pet food, diagnostics, and other services aimed at maintaining the health and well-being of livestock. Over the years, Abbott Laboratories has received numerous awards for its products and achievements. The company is committed to improving the quality of life for people worldwide and contributes to optimizing healthcare. Abbott Laboratories is among the top 15 leading pharmaceutical and healthcare companies worldwide and currently employs around 103,000 people in over 160 countries. Abbott Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Abbott Laboratories stock

Book Value per Share of Abbott Laboratories is 29.82 USD in 2025.

Book Value per Share of Abbott Laboratories changed from 27.27 USD to 29.82 USD, representing a 9.37% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Book Value per Share Abbott Laboratories since 2006 – with annual values, charts, and detailed analysis.

Book value per share represents the net asset value of the company per outstanding share. Comparing it to the stock price helps assess whether a stock is undervalued.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Abbott Laboratories

All Key Metrics — Abbott Laboratories